Market Exclusive

Analyst Activity – Wells Fargo & Co Reiterates Outperform on Iovance Biotherapeutics (NASDAQ:IOVA)

Analyst Ratings For Iovance Biotherapeutics (NASDAQ:IOVA)

Today, Wells Fargo & Co reiterated its Outperform rating on Iovance Biotherapeutics (NASDAQ:IOVA) with a price target of $23.00.

Some recent analyst ratings include

Recent Insider Trading Activity For Iovance Biotherapeutics (NASDAQ:IOVA)
Iovance Biotherapeutics (NASDAQ:IOVA) has insider ownership of 13.20% and institutional ownership of 76.35%.

Recent Trading Activity for Iovance Biotherapeutics (NASDAQ:IOVA)
Shares of Iovance Biotherapeutics closed the previous trading session at 13.48 down -0.22 1.64% with 13.300000190734863 shares trading hands.

Exit mobile version